- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Hematologic Malignancy in New Zealand
Total 3401 results
-
Malaghan Institute of Medical ResearchRecruitingLymphoma | Leukemia | Myeloma | Temperature Change, Body | Haematological MalignancyNew Zealand
-
NYU Langone HealthWithdrawnCancer | Hematological MalignancyUnited States
-
SanofiCompletedHematological MalignancyGreece, Spain, Peru, Israel, United States, Argentina, Belgium, Brazil, Chile, Finland, France, Italy, Mexico, Russian Federation, Turkey, Ukraine, United Kingdom
-
CRISPR Therapeutics AGEnrolling by invitationHematologic Malignancy | Solid MalignancyUnited States
-
Epizyme, Inc.WithdrawnRefractory Hematologic Malignancy | Relapsed Hematologic MalignancyUnited States
-
Hangzhou Sumgen Biotech Co., Ltd.RecruitingSG2501 Safety Study in Subjects With Relapsed or Refractory Hematological Malignancies and Lymphoma.Lymphoma | Hematological MalignancyUnited States
-
NYU Langone HealthActive, not recruitingHematologic MalignancyUnited States
-
Memorial Sloan Kettering Cancer CenterCompleted
-
Memorial Sloan Kettering Cancer CenterMillennium: The Takeda Oncology CompanyCompletedMyeloid Hematologic Malignancy | Lymphoid Hematologic MalignancyUnited States
-
Dartmouth-Hitchcock Medical CenterRecruitingCancer | Hematologic Malignancy | Blood Cancer | Tumor, SolidUnited States
-
University of SydneyUniversity of Roma La Sapienza; Australasian Bone Marrow Transplant Recipient... and other collaboratorsRecruiting
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingSolid Tumor | Hematologic Malignancy | Solid Tumor, Adult | Solid CarcinomaUnited States
-
Weill Medical College of Cornell UniversityActive, not recruitingHematologic Malignancy | Bone Marrow TransplantUnited States
-
Northwestern UniversityNational Cancer Institute (NCI); Hackensack Meridian Health; Lombardi Comprehensive...CompletedStem Cell Transplantation | Hematologic MalignancyUnited States
-
Memorial Sloan Kettering Cancer CenterTerminated
-
Memorial Sloan Kettering Cancer CenterCompletedLymphoma | Acute Myeloid Leukemia | Leukemia | Myelodysplastic Syndrome | Myeloma | Hematological MalignancyUnited States
-
Precision BioSciences, Inc.RecruitingHematologic Malignancy | CD19 Expressing MalignanciesUnited States
-
Memorial Sloan Kettering Cancer CenterAstellas Pharma US, Inc.CompletedHematologic Malignancy | Myeloproliferative DisorderUnited States
-
Matthew DallosBristol-Myers SquibbTerminatedSolid Tumor | Sars-CoV2 | Hematological MalignancyUnited States
-
Curis, Inc.RecruitingRelapsed Primary Central Nervous System Lymphoma | Refractory Hematologic Malignancy | Relapsed Hematologic Malignancy | Refractory Primary Central Nervous System LymphomaUnited States, Spain, France, Czechia, Israel, Italy, Poland
-
Sight DiagnosticsCompleted
-
Antisoma ResearchCompletedMetastatic Renal Cell Carcinoma | Metastatic Malignant MelanomaUnited Kingdom, New Zealand
-
Roswell Park Cancer InstituteCompletedMalignant Neoplasm | Parent | Hematologic and Lymphocytic Disorder | GuardianUnited States
-
Center for International Blood and Marrow Transplant...National Cancer Institute (NCI); National Heart, Lung, and Blood Institute... and other collaboratorsCompletedHematologic MalignancyUnited States
-
Alla KeyznerCompletedMyelodysplastic Syndromes | Hodgkin Lymphoma | Non-Hodgkin Lymphoma | Acute Leukemia in Remission | Hematological Malignancy | Acute Lymphoblastic Leukemia in RemissionUnited States
-
Duke UniversityNational Institute of Allergy and Infectious Diseases (NIAID); Weill Medical...CompletedNeutropenia | Hematologic Malignancy | Bloodstream Infection | Leukemia, AcuteUnited States
-
Zealand University HospitalUnknownHematological CancerDenmark
-
Smart Immune SASRecruitingHematological MalignanciesUnited States
-
Kura Oncology, Inc.RecruitingNeoplasms by Histologic Type | Acute Myeloid Leukemia | Leukemia | Leukemia, Myeloid | Leukemia, Myeloid, Acute | AML | Acute Leukemia | Hematologic Malignancy | NPM1 Mutation | AML With Mutated NPM1 | KMT2Ar | MLL RearrangementUnited States
-
Zealand University HospitalCompletedChronic Pain | Non-malignant PainDenmark
-
Incyte CorporationTerminatedSolid Tumors and Hematologic MalignancyUnited States, Netherlands, Belgium
-
Naestved HospitalTerminatedMalignant Pleural Effusion | Exudative Pleural EffusionDenmark
-
Albert Einstein College of MedicineRecruiting
-
University of Auckland, New ZealandLeukaemia & Blood Cancer New ZealandActive, not recruiting
-
Weill Medical College of Cornell UniversityMerck Sharp & Dohme LLCRecruitingPneumonia | Hematologic Malignancy | Pseudomonas AeruginosaUnited States
-
Orsenix LLCCompleted
-
Novartis PharmaceuticalsCompletedCancer Patients With Advanced Solid Tumors Including Lymphoma or Chronic Hematological MalignanciesUnited States
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI); Novartis PharmaceuticalsCompleted
-
AlexionAchillion, a wholly owned subsidiary of AlexionCompletedParoxysmal Nocturnal HemoglobinuriaNew Zealand, Korea, Republic of, Italy
-
Memorial Sloan Kettering Cancer CenterCivaTech OncologyActive, not recruitingAbdominal Malignancy | Pelvic MalignancyUnited States
-
Audubon BioscienceEnrolling by invitationCardiovascular Diseases | Autoimmune Diseases | Infectious Disease | Pregnancy Related | Hematologic Malignancy | Oncology | Renal Disease | Gastro-Intestinal Disorder | Genitourinary DiseaseUnited States
-
Esanex Inc.Completed
-
Apellis Pharmaceuticals, Inc.CompletedParoxysmal Nocturnal HemoglobinuriaHong Kong, Thailand, New Zealand, Malaysia
-
Kite, A Gilead CompanyEnrolling by invitationSolid and Hematological MalignanciesUnited States, Netherlands, Japan, Australia, France, Israel, Germany, Canada, United Kingdom
-
Hoffmann-La RocheCompletedMalignant Melanoma, NeoplasmsSpain, New Zealand, Hungary, Serbia, Germany, Portugal, Netherlands, Greece, Australia
-
HutchmedRecruitingIsocitrate Dehydrogenase Gene MutationSpain, United States
-
Kangpu Biopharmaceuticals, Ltd.RecruitingHematological MalignanciesUnited States
-
Aprea TherapeuticsCompletedMyeloid MalignancyUnited States
-
AdaptimmuneRecruitingSolid and Hematological MalignanciesUnited States, Spain, Canada, United Kingdom
-
Martin GutierrezHackensack Meridian Health; Karyopharm Therapeutics IncWithdrawn